Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

Those prescribed Wegovy or Zepbound or the combination of bupropion and naltrexone also showed a tendency to drink less.

It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

More than 7 million Americans struggling with obesity would become eligible for coverage under the proposed change ...

Dear S.R.: Tirzepatide (Zepbound), like semaglutide, is a prescription medication originally used for diabetes but now ...

Analyst Terence Flynn from Morgan Stanley maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and increased the price target ...

The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly’s ...

This is a prescription medication originally used for diabetes but now approved for weight loss. Most people regained weight ...

Zepbound, a drug used to help patients lose weight and manage diabetes, may also help those with heart failure, a new trial ...

The outgoing Biden administration is proposing to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...

The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...

My husband and I have started taking Zepbound for various medical reasons. The medication has significantly and positively ...